IP Library Granted Patent US 9,555,111
Granted Patent B2
US 9,555,111 · App. 14/387,532 · Granted Jan 31, 2017

Ocular cross-linking system and method for sealing corneal wounds

Inventors: Roy S. Rubinfeld (Bethesda, MD); Raymond A. Hartman (Carlsbad, CA); Sandy T. Feldman (Del Mar, CA)
Assignee: CXL Ophthalmics, LLC
A61K41/0057A61F9/008A61F9/0079A61K9/0048A61K31/525A61K33/18A61K38/44A61K41/00A61N5/062A61B2018/0063A61B2018/00619A61F2009/00865A61F2009/00872A61N2005/063A61N2005/067A61N2005/0626A61N2005/0661A61N2005/0662A61N2005/0663A61N2005/0667C12Y111/01006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,111
App. No.
14/387,532
Granted
Jan 31, 2017
Kind
B2
Abstract

Wounds in the eye following surgery or injury are sealed by soaking the area with a riboflavin solution containing iodide ion and irradiating the wound area with UVA radiation in a selected wavelength range for a selected time period to promote cross-linking of tissue between opposite surfaces of the wound or between the incised wound surfaces and a graft or implant.

Claims (20)

1. A corneal collagen cross-linking system, the system comprising:

(a) a supply of a photosensitizer solution that promotes photochemical cross-linking in eye tissue, the photosensitizer solution comprising a hypotonic or aqueous solution containing

(i) 0.5 wt. % riboflavin, and

(ii) 0.015 wt. % to 5 wt. % sodium iodide, wherein the iodide is in ionized (I − ) form and the solution maintains a basic pH that permits iodide ion to catalytically break hydrogen peroxide into water and oxygen; and

(b) a light source having an output in a selected UVA or UVA/blue or blue light range.

2. The corneal collagen cross-linking system of claim 1 , further comprising an adjustable optical treatment head, the treatment head comprising an optical projector defining an optical axis and configured to project a beam of light in a predetermined UVA or UVA/blue or blue light range along the optical axis.

3. The corneal collagen cross-linking system of claim 1 , further comprising a positioning control element for adjusting distance from the eye and the orientation of the optical axis relative to an axis of the eye.

4. The corneal collagen cross-linking of claim 1 , further comprising a beam intensity adjustment module for adjusting the light intensity incident on the eye.

5. The corneal collagen cross-linking system of claim 1 , further comprising a control module that controls a treatment time period.

6. The corneal collagen cross-linking system of claim 2 , wherein the adjustable optical treatment head is adjustable in at least one of an x-axis, a y-axis, and a z-axis.

7. The corneal collagen cross-linking system of claim 1 , wherein the UVA or UVA/blue radiation is in a wavelength range from 320 nm to 500 nm.

8. The corneal collagen cross-linking system of claim 1 , wherein the UVA radiation is in a wavelength range from 330 nm to 380 nm.

9. The corneal collagen cross-linking system of claim 1 , wherein the UVA/blue radiation is in a wavelength range from 400 to 470 nm.

10. The corneal collagen cross-linking system of claim 1 , wherein the UVA or UVA/blue radiation is in a wavelength range from 400 to 410 nm.

11. The corneal collagen cross-linking system of claim 1 , wherein the basic pH is between 7 and 8.4, not including 7.

12. A corneal collagen cross-linking system, the system comprising:

(a) a supply of a photosensitizer solution that promotes photochemical cross-linking in eye tissue, the photosensitizer solution comprising a hypotonic or aqueous solution containing

(i) 0.5 wt. % riboflavin, and

(ii) 0.015 wt. % sodium iodide, wherein the iodide is in ionized (I − ) form and the solution maintains a basic pH that permits iodide ion to catalytically break hydrogen peroxide into water and oxygen; and

(b) a light source having an output in a selected UVA or UVA/blue or blue light range.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2014
From: RUBINFELD, ROY S.; FELDMAN, SANDY T.; HARTMAN, RAYMOND A.
To: CXL OPHTHALMICS, LLC
Reel/Frame 033801/0966 →
Continuity (2)
Provisional Application 61617326 · Mar 29, 2012
Related Publication 20150126921A1 · May 7, 2015